This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Proximal Tibial Fractures

This study is currently recruiting participants.
See Contacts and Locations
Verified December 2016 by Paul Tornetta, III, M.D., Boston Medical Center
Sponsor:
Information provided by (Responsible Party):
Paul Tornetta, III, M.D., Boston Medical Center
ClinicalTrials.gov Identifier:
NCT00429585
First received: January 30, 2007
Last updated: December 15, 2016
Last verified: December 2016
  Purpose
This study looks at two types of surgical treatments and hopes to answer the question: which is the best way to surgically treat a proximal tibia fracture? Both procedures being studied are standard of care (used routinely) and use FDA approved devices. All medical and surgical treatment will be the same for participants as non-participants.

Condition Intervention
Tibial Fractures Device: reamed, interlocking intramedullary nail Device: locking periarticular plate

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Intramedullary Nail Versus Plate Fixation Re-Evaluation Study in Proximal Tibial Fractures: A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation (IMPRESS)

Resource links provided by NLM:


Further study details as provided by Paul Tornetta, III, M.D., Boston Medical Center:

Primary Outcome Measures:
  • SF-12v2 [ Time Frame: pre-Op, 3, 6, 12, & 24 month follow-up ]
  • EQ-5D [ Time Frame: pre-Op, 3, 6, 12, & 24 month follow-up ]
  • SMFA [ Time Frame: pre-Op, 3, 6, 12, & 24 month follow-up ]
  • Knee Society Score [ Time Frame: 3, 6, 12, & 24 month follow-up ]
  • Clinical Assessment [ Time Frame: 2, 3, 6, 12, & 24 month follow-up ]

Secondary Outcome Measures:
  • Re-operation (secondary procedures) [ Time Frame: Up to 24 months post-op ]
  • nonunion [ Time Frame: Until radiographically healed ]
  • superficial infection rates (wound only) [ Time Frame: Up to 24 months post op ]
  • deep infection (bone implant interface) [ Time Frame: Up to 24 months post op ]
  • compartment syndrome [ Time Frame: Up to 24 months post op ]
  • malunion (>5 degrees varus/valgus) [ Time Frame: Up until radiographically healed ]
  • >5 degrees anterior or posterior angulation [ Time Frame: Up until radiographically healed ]
  • >10 malrotation degrees, and >1cm shortening) [ Time Frame: Up until radiographically healed ]
  • knee range of motion [ Time Frame: Up to 24 months post op ]

Estimated Enrollment: 160
Study Start Date: February 2007
Estimated Study Completion Date: December 2019
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Randomized Treatment - Nail
Randomized Treatment - Nail
Device: reamed, interlocking intramedullary nail
Standard of care device for tibia fracture repair; Randomized Treatment - Nail
Randomized Treatment - Plate
Randomized Treatment - Plate
Device: locking periarticular plate
Standard of care device for tibia fracture repair; Randomized Treatment - Plate

Detailed Description:
The study is a multicenter randomized controlled trial in which individuals sustaining a fracture of the proximal metaphysis of the tibia will be operatively managed by one of two strategies. The first strategy involves fixation of the fracture with a reamed, interlocking intramedullary nail (Nail Group). The second treatment strategy involves open reduction and internal fixation of the fracture with a locking periarticular plate (Plate Group). The null hypothesis of the study is that there will be no difference in the two groups with respect to the primary and secondary outcome measures. To the degree possible, patients in the two groups will receive post-operative care according to the same standards and protocols.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Skeletally mature,
  • Extra-articular fracture of the proximal tibia extending into the metaphyseal with or without intra-articular extension not requiring open reduction with complete AP and lateral radiographs,
  • Major fracture line not closer than 4cm from the proximal tibial articular surface
  • Fracture requiring operative treatment amenable to either IM nail or plate
  • Surgeon agreed to randomize patient
  • Informed consent obtained
  • Patient is English speaking

Exclusion Criteria:

  • Tibial shaft fractures not amenable to intramedullary nailing (i.e.fracture is less than 4 cm from joint surface),
  • Fracture of the proximal tibia with intraarticular extension requiring open reduction,
  • Known metabolic bone disease
  • Separate displaced tibial tubercle fragment,
  • Soft tissue injuries compromising treatment method with nail,plate or both.
  • Fractures with vascular injury (Gustillo Type IIIC injury) requiring repair,
  • Compartment syndrome of the leg diagnosed preoperatively,
  • Pathological fractures,
  • Retained hardware or existing deformity in the affected limb that would complicate IM nailing,plating or both,
  • Symptomatic knee arthritis.
  • Surgical delay greater than 3 weeks for closed fractures or 24 hours for open fractures,
  • Immunocompromised,
  • Unable to comply with postoperative rehabilitation protocols or instructions (i.e. head injured or mentally impaired),
  • Current or impending incarceration,
  • Unlikely to follow-up in surgeon's estimation.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00429585

Contacts
Contact: Paul Tornetta 617-414-6295 heather.desjardin@bmc.org
Contact: paul tornetta ptornetta@gmail.com

  Show 30 Study Locations
Sponsors and Collaborators
Boston Medical Center
Investigators
Principal Investigator: Paul Tornetta, M.D. Boston University
  More Information

Responsible Party: Paul Tornetta, III, M.D., Paul Tornetta, III, MD,, Boston Medical Center
ClinicalTrials.gov Identifier: NCT00429585     History of Changes
Other Study ID Numbers: H-25923
Study First Received: January 30, 2007
Last Updated: December 15, 2016

Keywords provided by Paul Tornetta, III, M.D., Boston Medical Center:
tibia fracture
proximal tibia

Additional relevant MeSH terms:
Fractures, Bone
Tibial Fractures
Wounds and Injuries
Leg Injuries

ClinicalTrials.gov processed this record on July 21, 2017